 MagicMed Industries Inc said in a corporate update that it will have more opportunities to bring new psychedelic therapies to market once its amalgamation with Enveric Biosciences Inc NASDAQ:ENVB closes. In the brief update, MagicMed told shareholders that the two companies are working diligently to finalize the definitive agreement to close their amalgamation. 